Helix Biopharma Corp HBPCF:OTCPK

RT Quote | Exchange | USD
Last | 04/07/22 EDT
0.1784UNCH (UNCH)
52 week range
0.18 - 0.81
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.1784
  • 52 Week High0.81
  • 52 Week High Date06/07/21
  • 52 Week Low0.18
  • 52 Week Low Date04/07/22

Key Stats

  • Market Cap23.5M
  • Shares Out143.34M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-28.64

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.1784
  • 52 Week High0.81
  • 52 Week High Date06/07/21
  • 52 Week Low0.18
  • 52 Week Low Date04/07/22
  • Market Cap23.5M
  • Shares Out143.34M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-28.64

RATIOS/PROFITABILITY

  • EPS (TTM)-0.05
  • P/E (TTM)-3.51
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Helix Biopharma Corp

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Helix BioPharma Corp. (Helix) is an immuno-oncology company that is developing drug candidates for the prevention and treatment of cancer. Helix’s proprietary technological platforms include DOS47, V-DOS47 and L-DOS47. The DOS47 is an oncology platform that offers a debilitation and destruction of cancer cells by modulating the tumor microenvironment. DOS47 is designed to stimulate an increase in the pH of the microenvironment surrounding the cancerous cells, effectively...
Photios Michalargias CPA
Chief Financial Officer
Address
9120 Leslie St Suite 205
Richmond Hill, ON
L4B 3J9
Canada